Home » Affymax Completes Phase III Program for Hematide to Treat Anemia
Affymax Completes Phase III Program for Hematide to Treat Anemia
Affymax, Inc. Monday announced completion of treatment and follow-up
of patients with anemia due to chronic renal failure enrolled in the four-trial, Phase 3 clinical program for the investigational drug Hematide.
Fox Business
Fox Business
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May